Clinical Approach to Jaundice
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of Jaundice
Jaundice is one of the most recognizable clinical signs in medicine, presenting as yellow discoloration of the skin, sclera, and mucous membranes. It affects approximately 1% of the general population at any given time, with significantly higher prevalence in hospitalized patients. In primary care settings, jaundice accounts for roughly 0.5-1% of adult consultations. While often indicating benign conditions such as Gilbert syndrome (affecting 5-10% of the population), jaundice can also herald life-threatening diseases including malignancy, acute liver failure, and sepsis. The ability to rapidly distinguish benign from serious causes is essential for every clinician.
Definition
Jaundice (also called icterus) is the yellowish pigmentation of the skin, sclerae, and mucous membranes caused by elevated serum bilirubin levels. Clinical jaundice typically becomes apparent when serum bilirubin exceeds 2.5-3.0 mg/dL (43-51 μmol/L), approximately 2-3 times the upper limit of normal. Scleral icterus is often the earliest detectable sign due to the high elastin content of the sclera, which has a strong affinity for bilirubin.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 2 weeks | Viral hepatitis, drug-induced liver injury, acute biliary obstruction, hemolysis, sepsis | Requires urgent evaluation to exclude acute liver failure, cholangitis, and malignant obstruction |
| Subacute | 2 to 12 weeks | Resolving hepatitis, biliary stricture, pancreatic head mass, medication effects | Warrants imaging and detailed workup; may indicate evolving malignancy or chronic liver disease |
| Chronic | Greater than 12 weeks | Cirrhosis, chronic biliary obstruction, Gilbert syndrome, primary biliary cholangitis, primary sclerosing cholangitis | Indicates established liver disease or hereditary condition; requires staging and long-term management planning |
Classification by Mechanism (The “Where” of Jaundice)
Pre-hepatic (Hemolytic)
Mechanism: Excess bilirubin production from red blood cell breakdown overwhelms hepatic conjugation capacity.
Bilirubin type: Predominantly unconjugated (indirect)
Key feature: Normal or mildly elevated liver enzymes; anemia often present
Hepatic (Hepatocellular)
Mechanism: Liver cell dysfunction impairs bilirubin uptake, conjugation, or excretion.
Bilirubin type: Mixed (both conjugated and unconjugated)
Key feature: Elevated transaminases (AST, ALT); may have synthetic dysfunction
Post-hepatic (Obstructive)
Mechanism: Mechanical blockage prevents conjugated bilirubin from reaching the intestine.
Bilirubin type: Predominantly conjugated (direct)
Key feature: Elevated alkaline phosphatase and gamma-glutamyl transferase; pale stools, dark urine
Classification by Bilirubin Fractionation
| Bilirubin Type | Fraction Elevated | Water Solubility | Urine Bilirubin | Clinical Implications |
|---|---|---|---|---|
| Unconjugated (Indirect) Hyperbilirubinemia | Greater than 80% unconjugated | Lipid-soluble (bound to albumin) | Absent (cannot be filtered) | Suggests hemolysis or impaired conjugation (Gilbert syndrome, Crigler-Najjar syndrome) |
| Conjugated (Direct) Hyperbilirubinemia | Greater than 50% conjugated | Water-soluble | Present (dark urine) | Suggests hepatocellular disease or biliary obstruction; requires imaging |
| Mixed Hyperbilirubinemia | Both fractions elevated | Variable | Usually present | Common in hepatocellular disease; suggests multiple mechanisms involved |
Classification by Associated Features
| Clinical Pattern | Associated Features | Suggests |
|---|---|---|
| Painless jaundice | Progressive, deep jaundice with weight loss; palpable gallbladder (Courvoisier sign) | Malignant obstruction (pancreatic head cancer, cholangiocarcinoma) |
| Painful jaundice | Right upper quadrant pain, fever, rigors (Charcot triad) | Choledocholithiasis with cholangitis |
| Jaundice with encephalopathy | Confusion, asterixis, coagulopathy | Acute liver failure or decompensated cirrhosis |
| Fluctuating mild jaundice | Worsens with fasting, stress, illness; otherwise asymptomatic | Gilbert syndrome (benign) |
| Jaundice with pruritus | Intense itching, often preceding jaundice; xanthomas may be present | Cholestatic disorders (primary biliary cholangitis, drug-induced cholestasis) |
| Jaundice with dark urine and pale stools | “Tea-colored” urine; acholic (clay-colored) stools | Biliary obstruction (conjugated bilirubin cannot reach intestine) |
Key Concept — The Three Questions: When evaluating jaundice, systematically answer three questions:
- Is it conjugated or unconjugated? — Fractionated bilirubin guides the entire workup
- Is it hepatocellular or cholestatic? — Enzyme pattern (AST/ALT versus alkaline phosphatase/gamma-glutamyl transferase) distinguishes these
- If cholestatic, is it intrahepatic or extrahepatic? — Imaging (ultrasound) answers this by showing dilated ducts or not
Epidemiology and Impact
- Gilbert syndrome: Affects 5-10% of the population; most common cause of isolated unconjugated hyperbilirubinemia
- Gallstone disease: Present in 10-15% of adults; leading cause of obstructive jaundice
- Viral hepatitis: Hepatitis A, B, and C remain major causes worldwide; Hepatitis E increasingly recognized
- Alcohol-related liver disease: Accounts for approximately 50% of cirrhosis cases in Western countries
- Pancreatic cancer: Jaundice is the presenting symptom in 70-80% of pancreatic head tumors
2. Pathophysiology and Mechanisms
Understanding bilirubin metabolism and the mechanisms of jaundice
Understanding bilirubin metabolism is fundamental to interpreting jaundice. Bilirubin is the end product of heme degradation, primarily from senescent red blood cells. Approximately 250-300 mg of bilirubin is produced daily in adults. The journey from heme to bilirubin excretion involves multiple steps, and dysfunction at any point along this pathway can result in jaundice.
The Bilirubin Metabolic Pathway
| Step | Location | Process | Clinical Relevance |
|---|---|---|---|
| 1. Heme Release | Reticuloendothelial system (spleen, liver, bone marrow) | Senescent red blood cells are phagocytosed; hemoglobin is broken down to release heme | Increased hemolysis (hemolytic anemia) overwhelms this step, producing excess bilirubin |
| 2. Biliverdin Formation | Reticuloendothelial system | Heme oxygenase converts heme to biliverdin (green pigment) plus carbon monoxide and iron | This is the rate-limiting step in bilirubin production |
| 3. Unconjugated Bilirubin | Reticuloendothelial system | Biliverdin reductase converts biliverdin to unconjugated bilirubin (yellow pigment) | Unconjugated bilirubin is lipid-soluble and must bind albumin for transport |
| 4. Hepatic Uptake | Hepatocyte sinusoidal membrane | Unconjugated bilirubin-albumin complex reaches liver; bilirubin is taken up by hepatocytes via OATP transporters | Impaired uptake occurs in Gilbert syndrome and some drug interactions |
| 5. Conjugation | Hepatocyte endoplasmic reticulum | UDP-glucuronosyltransferase (UGT1A1) conjugates bilirubin with glucuronic acid, making it water-soluble | Deficient in Gilbert syndrome (mild) and Crigler-Najjar syndrome (severe) |
| 6. Canalicular Excretion | Hepatocyte canalicular membrane | MRP2 transporter actively secretes conjugated bilirubin into bile canaliculi | Defective in Dubin-Johnson syndrome; impaired in intrahepatic cholestasis |
| 7. Intestinal Processing | Terminal ileum and colon | Bacterial enzymes convert conjugated bilirubin to urobilinogen; most is excreted in stool (stercobilin gives stool brown color) | Absent stool color (acholic stool) indicates complete biliary obstruction |
| 8. Enterohepatic Circulation | Intestine → portal circulation → liver | Some urobilinogen is reabsorbed and re-excreted by liver; small amount reaches kidneys (gives urine yellow color) | Increased urobilinogen in urine suggests hemolysis or hepatocellular dysfunction |
Properties of Bilirubin Fractions
Unconjugated (Indirect) Bilirubin
Solubility: Lipid-soluble only
Transport: Bound tightly to albumin in blood
Renal excretion: Cannot be filtered (too large when bound)
Toxicity: Can cross blood-brain barrier if very high (kernicterus in neonates)
Urine test: Negative for bilirubin
Conjugated (Direct) Bilirubin
Solubility: Water-soluble
Transport: Loosely bound to albumin; can exist free in plasma
Renal excretion: Can be filtered and excreted in urine
Toxicity: Non-toxic (does not cross blood-brain barrier)
Urine test: Positive for bilirubin (dark “tea-colored” urine)
How Different Conditions Cause Jaundice
Pre-hepatic (Hemolytic) Causes
| Condition | Mechanism | Distinguishing Features |
|---|---|---|
| Autoimmune hemolytic anemia | Antibodies target red blood cells, causing premature destruction in spleen; heme release exceeds liver conjugation capacity | Positive direct Coombs test; spherocytes on blood smear; reticulocytosis |
| Hereditary spherocytosis | Defective red cell membrane proteins cause spherical, fragile cells that are trapped and destroyed in spleen | Family history; splenomegaly; spherocytes; increased osmotic fragility |
| Glucose-6-phosphate dehydrogenase deficiency | Oxidant stress causes hemoglobin denaturation (Heinz bodies) and red cell destruction | Episodic hemolysis after oxidant exposure (fava beans, certain drugs); bite cells |
| Sickle cell disease | Chronic hemolysis from sickling; also prone to gallstones from chronic bilirubin overload | Sickle cells on smear; known diagnosis; may have pigment gallstones |
| Massive transfusion | Breakdown of transfused red cells (especially older units) releases large bilirubin load | History of recent transfusion; peaks 5-7 days post-transfusion |
Hepatic (Hepatocellular) Causes
| Condition | Mechanism | Distinguishing Features |
|---|---|---|
| Viral hepatitis (Hepatitis A, B, C, E) | Viral infection causes hepatocyte inflammation and necrosis; impaired uptake, conjugation, and excretion of bilirubin | Prodrome of fatigue, nausea; markedly elevated transaminases (often greater than 1000 U/L); positive viral serologies |
| Alcoholic hepatitis | Alcohol-induced hepatocyte injury with steatosis, inflammation, and impaired bile secretion | Heavy alcohol use; AST:ALT ratio typically greater than 2:1; elevated gamma-glutamyl transferase |
| Drug-induced liver injury | Drug metabolites cause direct toxicity or immune-mediated hepatocyte destruction | Temporal relationship with drug exposure; improvement after drug withdrawal |
| Cirrhosis | Extensive fibrosis reduces functional hepatocyte mass; architectural distortion impairs bile flow | Stigmata of chronic liver disease; portal hypertension features; coagulopathy |
| Gilbert syndrome | Reduced UGT1A1 enzyme activity (approximately 30% of normal) impairs conjugation; benign condition | Mild unconjugated hyperbilirubinemia; normal liver enzymes; worsens with fasting |
| Acute liver failure | Massive hepatocyte necrosis causes complete loss of metabolic function | Encephalopathy; severe coagulopathy (INR greater than 1.5); rapidly rising bilirubin |
Post-hepatic (Obstructive/Cholestatic) Causes
| Condition | Mechanism | Distinguishing Features |
|---|---|---|
| Choledocholithiasis | Gallstone migrates into common bile duct, causing mechanical obstruction to bile flow | Colicky right upper quadrant pain; may have Charcot triad if infected; ultrasound shows dilated ducts |
| Pancreatic head cancer | Tumor compresses or invades distal common bile duct | Painless progressive jaundice; weight loss; palpable gallbladder (Courvoisier sign) |
| Cholangiocarcinoma | Malignant growth within bile ducts causes obstruction | Jaundice, pruritus, weight loss; may be associated with primary sclerosing cholangitis |
| Primary biliary cholangitis | Autoimmune destruction of small intrahepatic bile ducts causes intrahepatic cholestasis | Middle-aged women; antimitochondrial antibodies positive; pruritus often precedes jaundice |
| Primary sclerosing cholangitis | Progressive fibrosis and stricturing of intrahepatic and extrahepatic bile ducts | Often associated with inflammatory bowel disease; “beaded” appearance on cholangiography |
| Drug-induced cholestasis | Drugs impair bile acid transport proteins (BSEP, MRP2) causing intrahepatic cholestasis | Temporal relationship with drug (anabolic steroids, oral contraceptives, antibiotics) |
Understanding Liver Enzyme Patterns
| Pattern | Predominant Enzymes Elevated | Mechanism | Typical Causes |
|---|---|---|---|
| Hepatocellular Pattern | AST and ALT elevated (often greater than 300 U/L); alkaline phosphatase normal or mildly elevated | Hepatocyte injury releases intracellular enzymes | Viral hepatitis, drug-induced liver injury, ischemic hepatitis, autoimmune hepatitis |
| Cholestatic Pattern | Alkaline phosphatase and gamma-glutamyl transferase markedly elevated; AST/ALT normal or mildly elevated | Bile duct obstruction or damage induces enzyme production in biliary epithelium | Choledocholithiasis, pancreatic cancer, primary biliary cholangitis, drug-induced cholestasis |
| Mixed Pattern | Both transaminases and alkaline phosphatase significantly elevated | Combined hepatocyte injury and cholestasis | Drug reactions, infiltrative diseases, cholangitis with hepatic involvement |
| Isolated Hyperbilirubinemia | Bilirubin elevated; all other liver enzymes normal | Problem is in bilirubin metabolism only, not liver cell injury | Gilbert syndrome, hemolysis, Dubin-Johnson syndrome, Rotor syndrome |
The R Ratio (R Factor): A useful tool to classify liver injury patterns
Formula: R = (ALT ÷ upper limit of normal for ALT) ÷ (Alkaline phosphatase ÷ upper limit of normal for alkaline phosphatase)
- R greater than 5: Hepatocellular injury pattern
- R less than 2: Cholestatic injury pattern
- R between 2 and 5: Mixed pattern
Often Overlooked Mechanism: Sepsis-Associated Jaundice
Sepsis can cause jaundice through multiple mechanisms that are frequently underrecognized:
- Cytokine-mediated cholestasis: Inflammatory cytokines (interleukin-6, tumor necrosis factor-alpha) downregulate bile transporters
- Hepatic hypoperfusion: Septic shock causes ischemic hepatocyte injury
- Hemolysis: Disseminated intravascular coagulation causes microangiopathic hemolysis
- Drug toxicity: Multiple antibiotics and vasopressors can contribute
In critically ill patients, jaundice may be the first sign of occult infection. Always consider sepsis in unexplained jaundice, especially in elderly or immunocompromised patients.
Delta Bilirubin: Why Jaundice Persists After Resolution
When conjugated hyperbilirubinemia persists (as in prolonged obstruction), conjugated bilirubin covalently binds to albumin, forming delta bilirubin (also called biliprotein). This fraction:
- Has a half-life matching albumin (approximately 17-20 days) rather than bilirubin (4 hours)
- Cannot be excreted by the kidneys
- Explains why jaundice may persist for weeks after obstruction is relieved
- Is not clinically harmful but may cause diagnostic confusion
3. History Taking
A comprehensive approach to eliciting the jaundice history
Red Flags — Require Urgent Evaluation
- Fever with rigors and right upper quadrant pain — Ascending cholangitis (Charcot triad); can progress to sepsis within hours
- Altered mental status or confusion — Hepatic encephalopathy; suggests acute liver failure or decompensated cirrhosis
- Easy bruising or bleeding — Coagulopathy from synthetic liver failure; INR should be checked urgently
- Rapid onset with high fever — Acute viral hepatitis, leptospirosis, or sepsis-associated jaundice
- Painless progressive jaundice with weight loss — Malignancy (pancreatic cancer, cholangiocarcinoma) until proven otherwise
- Pregnancy with jaundice — HELLP syndrome, acute fatty liver of pregnancy, intrahepatic cholestasis of pregnancy
- Recent acetaminophen use or overdose — Acute liver failure; N-acetylcysteine may be indicated
- Hypotension or signs of shock — Septic shock, massive hemolysis, or ischemic hepatitis
Systematic History: The “YELLOW” Approach
Use the mnemonic “YELLOW” to ensure comprehensive history taking for jaundice:
- Y — Yesterday or Years? (Timeline): When did the yellow color first appear? Sudden onset (days) versus gradual (weeks to months)? Any fluctuation?
- E — Excretions (Urine and Stool): Has urine become darker (“tea-colored” or “cola-colored”)? Have stools become pale, clay-colored, or acholic? These suggest biliary obstruction.
- L — Location of Pain: Any abdominal pain? Right upper quadrant (biliary)? Epigastric radiating to back (pancreatic)? Colicky versus constant?
- L — Liver Risks (Exposures): Alcohol use (quantity, duration)? Intravenous drug use? Blood transfusions? Tattoos? Sexual history? Recent travel?
- O — Other Symptoms: Fever, chills, night sweats? Pruritus (itching)? Weight loss? Fatigue? Nausea, vomiting, anorexia?
- W — What Medications?: All prescription drugs, over-the-counter medications, herbal supplements, and recreational drugs. Recent changes or new medications?
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Choledocholithiasis (common bile duct stone) | Colicky right upper quadrant pain, often post-prandial; may have history of gallstones | “Have you had episodes of severe pain in the upper right abdomen, especially after eating fatty foods?” |
| Ascending cholangitis | Charcot triad: fever, jaundice, right upper quadrant pain; Reynolds pentad adds confusion and hypotension | “Have you had shaking chills or high fever along with the abdominal pain and jaundice?” |
| Pancreatic head cancer | Painless progressive jaundice, weight loss, new-onset diabetes in elderly | “Has the yellow color been gradually getting worse without much pain? Have you lost weight unintentionally?” |
| Viral hepatitis | Prodrome of fatigue, nausea, anorexia; dark urine precedes jaundice; exposure history | “Did you feel unwell with fatigue, nausea, or loss of appetite for a few days before the jaundice appeared?” |
| Alcoholic hepatitis | Heavy recent alcohol use; tender hepatomegaly; fever may be present | “How much alcohol do you drink on a typical day? Have you been drinking more heavily recently?” |
| Drug-induced liver injury | Temporal relationship with drug initiation (usually 1-8 weeks); may have rash, eosinophilia | “Have you started any new medications, supplements, or herbal products in the past 2-3 months?” |
| Hemolytic anemia | Fatigue, pallor, dark urine (hemoglobinuria); may have splenomegaly | “Have you noticed unusual fatigue, shortness of breath, or very dark urine? Any family history of anemia or jaundice?” |
| Gilbert syndrome | Recurrent mild jaundice; worsens with fasting, illness, stress; otherwise healthy | “Has your jaundice come and gone over the years? Does it seem worse when you’re unwell or haven’t eaten?” |
| Primary biliary cholangitis | Middle-aged women; pruritus often precedes jaundice; fatigue; xanthomas | “Have you had persistent itching, sometimes for months or years? Any fatty deposits around your eyes?” |
| Primary sclerosing cholangitis | Often associated with inflammatory bowel disease; episodic jaundice and pruritus | “Do you have a history of ulcerative colitis or Crohn’s disease? Has the jaundice come and gone?” |
| Acute liver failure | Rapid onset; encephalopathy; coagulopathy; no prior liver disease | “Have you taken large amounts of acetaminophen or any other medication recently? Any confusion or drowsiness?” |
| Cirrhosis (decompensated) | Known or suspected chronic liver disease; ascites, edema, varices | “Have you noticed your belly swelling, or your ankles becoming puffy? Any history of liver problems?” |
Characterizing Abdominal Pain in Jaundice
| Pain Characteristic | Description | Suggests |
|---|---|---|
| Biliary colic | Severe, steady pain in right upper quadrant or epigastrium; lasts 30 minutes to several hours; often post-prandial | Choledocholithiasis |
| Constant right upper quadrant pain with fever | Unremitting pain; associated with high fever, rigors, tachycardia | Cholangitis (surgical emergency) |
| Epigastric pain radiating to back | Deep, boring pain; worse supine; improved leaning forward | Pancreatic pathology (cancer, pancreatitis) |
| Vague right upper quadrant discomfort | Dull, constant ache; associated with hepatomegaly | Hepatitis, hepatic congestion, infiltrative disease |
| No pain (painless jaundice) | Progressive jaundice without significant pain | Malignancy (pancreatic cancer, cholangiocarcinoma); Gilbert syndrome |
Medication and Substance History
Medications That Cause Hepatocellular Injury
- Acetaminophen (paracetamol) — Direct toxicity; dose-dependent; most common cause of acute liver failure
- Isoniazid — Idiosyncratic; usually within first 6 months of treatment
- Statins — Rare but well-documented; usually reversible
- Amiodarone — Can cause steatohepatitis resembling alcoholic hepatitis
- Methotrexate — Cumulative dose-related fibrosis and cirrhosis
- Phenytoin — Hypersensitivity reaction; often with rash and eosinophilia
- Valproic acid — Idiosyncratic hepatotoxicity; more common in children
- Herbal supplements — Green tea extract, kava, black cohosh, others
Medications That Cause Cholestatic Injury
- Amoxicillin-clavulanate — Most common antibiotic cause; onset often delayed
- Oral contraceptives — Estrogen-induced cholestasis; usually reversible
- Anabolic steroids — Bland cholestasis without inflammation
- Erythromycin — Cholestatic hepatitis; can mimic biliary obstruction
- Chlorpromazine — Classic drug-induced cholestasis
- Trimethoprim-sulfamethoxazole — Cholestatic or mixed pattern
- Azathioprine — Can cause veno-occlusive disease or cholestasis
- Total parenteral nutrition — Prolonged use causes cholestasis
Social, Occupational, and Exposure History
| Exposure Category | Specific Questions | Relevance |
|---|---|---|
| Alcohol | Type, quantity, frequency, duration. CAGE questionnaire. Recent binge drinking? | Alcoholic hepatitis typically requires sustained heavy use (greater than 40g/day women, greater than 60g/day men); recent increase often precedes acute presentation |
| Intravenous drug use | Current or past use? Needle sharing? Duration? | Hepatitis B and C transmission; increased risk of HIV co-infection |
| Sexual history | Number of partners, same-sex contact, history of sexually transmitted infections | Hepatitis B (sexually transmitted); Hepatitis A (men who have sex with men) |
| Blood transfusions | Prior to 1992? Location of transfusion? | Hepatitis C screening not available before 1992; higher risk in some countries |
| Tattoos and piercings | Where obtained? Professional or amateur setting? | Hepatitis B and C transmission from non-sterile equipment |
| Travel | Recent travel to endemic areas? Water and food sources? | Hepatitis A and E (fecal-oral); leptospirosis; malaria (hemolysis) |
| Occupation | Healthcare worker? Industrial chemical exposure? | Needlestick injuries (Hepatitis B, C); industrial solvents (toxic hepatitis) |
| Family history | Liver disease? Jaundice in relatives? Anemia? | Hereditary hemolytic anemias; Wilson disease; hemochromatosis; Gilbert syndrome |
| Household contacts | Anyone else with jaundice or hepatitis at home? | Hepatitis A outbreaks; shared exposure sources |
Significance of Associated Symptoms
| Associated Symptom | Description | Diagnostic Significance |
|---|---|---|
| Pruritus (itching) | Generalized itching, often worse at night; may precede jaundice | Suggests cholestasis (biliary obstruction or intrahepatic cholestasis); bile salt deposition in skin |
| Weight loss | Unintentional loss of greater than 5% body weight | Malignancy (pancreatic cancer, cholangiocarcinoma); advanced cirrhosis; chronic infection |
| Fever and chills | High spiking fevers with rigors | Cholangitis (biliary sepsis); viral hepatitis prodrome; abscess |
| Nausea and anorexia | Loss of appetite, food aversion, especially to fatty foods | Viral hepatitis prodrome; biliary disease; hepatic dysfunction |
| Fatigue | Persistent, disproportionate tiredness | Chronic liver disease; anemia from hemolysis; malignancy |
| Abdominal distension | Increasing abdominal girth; clothes no longer fit | Ascites from portal hypertension; peritoneal carcinomatosis |
| Ankle swelling | Bilateral pitting edema | Hypoalbuminemia from synthetic liver failure; right heart failure |
| Confusion or drowsiness | Altered mental status; day-night reversal; asterixis | Hepatic encephalopathy — indicates severe liver dysfunction or acute liver failure |
Practical Tip: The “First Noticed” Question
Ask patients: “Who first noticed the yellow color — you or someone else?”
- Patient noticed first: Often looking in mirror; may notice dark urine before skin changes — suggests more gradual onset
- Family member or friend noticed: Scleral icterus is often visible to others before the patient is aware — can help establish timeline
- Also ask: “Have you looked at old photographs to compare?” — Helpful for establishing chronicity
4. Physical Examination
A systematic head-to-toe approach for Jaundice
Systematic Framework: Use the “Head to Extremities” approach with special attention to stigmata of chronic liver disease, signs of portal hypertension, and clues to the underlying etiology of jaundice.
General Inspection
- Degree of jaundice: Mild scleral icterus versus deep yellow-green discoloration; greenish tinge suggests prolonged conjugated hyperbilirubinemia
- Nutritional status: Cachexia suggests malignancy or advanced cirrhosis; obesity is a risk factor for fatty liver disease
- Mental status: Alert and oriented versus drowsy, confused, or agitated (hepatic encephalopathy)
- Respiratory pattern: Tachypnea may indicate metabolic acidosis or sepsis
- Scratch marks: Excoriations from pruritus suggest cholestasis
- Fetor hepaticus: Sweet, musty breath odor indicates severe hepatic dysfunction
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C / 100.4°F); hypothermia in severe sepsis | Fever with jaundice: cholangitis, viral hepatitis, liver abscess, sepsis. Cholangitis is a surgical emergency. |
| Heart Rate | Tachycardia (greater than 100 bpm); bradycardia in severe cases | Tachycardia suggests sepsis, anemia (hemolysis), or hypovolemia. Bradycardia may occur with severe obstructive jaundice (bile salt effects). |
| Blood Pressure | Hypotension (systolic less than 90 mmHg); wide pulse pressure in cirrhosis | Hypotension: septic shock (cholangitis), hypovolemia, variceal bleeding. Cirrhosis causes hyperdynamic circulation. |
| Respiratory Rate | Tachypnea (greater than 20 breaths/min) | May indicate metabolic acidosis, sepsis, hepatopulmonary syndrome, or pleural effusion. |
| Oxygen Saturation | Hypoxemia (SpO2 less than 95%), especially when standing (orthodeoxia) | Hepatopulmonary syndrome in cirrhosis; platypnea-orthodeoxia (worse when upright). |
Head and Neck Examination
Eyes
- Scleral icterus: Best seen in natural light; examine under upper eyelid for early detection
- Kayser-Fleischer rings: Golden-brown rings at corneal limbus (Wilson disease) — requires slit lamp for definitive identification
- Xanthelasma: Yellow plaques around eyelids (primary biliary cholangitis, hyperlipidemia)
- Pale conjunctivae: Suggests anemia (hemolysis or chronic disease)
Face and Mouth
- Parotid enlargement: Bilateral, non-tender (chronic alcohol use)
- Temporal wasting: Loss of temporal muscle mass (malnutrition, malignancy)
- Angular stomatitis: Vitamin deficiency in malabsorption or chronic liver disease
- Fetor hepaticus: Sweet, musty odor on breath (severe hepatic dysfunction)
- Glossitis: Smooth, red tongue (vitamin B12, iron deficiency)
Neck
- Jugular venous pressure: Elevated JVP suggests right heart failure (cardiac cirrhosis, constrictive pericarditis) or fluid overload
- Lymphadenopathy: Left supraclavicular node (Virchow node) — suggests gastrointestinal malignancy with metastasis
- Hepatojugular reflux: Sustained JVP elevation with abdominal pressure suggests right heart failure
Chest Examination
Skin Findings
- Spider angiomata (spider nevi): Central arteriole with radiating vessels; blanch with pressure; found in superior vena cava distribution. Greater than 5 suggests chronic liver disease.
- Gynecomastia: Breast tissue enlargement in males (estrogen excess in cirrhosis)
- Loss of axillary hair: Hormone changes in chronic liver disease
Cardiorespiratory
- Pleural effusion: Reduced breath sounds, dullness to percussion (hepatic hydrothorax — usually right-sided)
- Heart sounds: S3 gallop (cardiac failure as cause of hepatic congestion)
- Pericardial rub or distant heart sounds: Constrictive pericarditis causing cardiac cirrhosis
Abdominal Examination
Inspection
- Abdominal distension: Ascites (flanks bulge when supine; umbilicus everted)
- Caput medusae: Dilated periumbilical veins radiating outward (portal hypertension)
- Surgical scars: Previous cholecystectomy, liver transplant, or other abdominal surgery
- Visible masses: Hepatomegaly, splenomegaly, or distended gallbladder visible
Palpation
| Finding | Technique | Clinical Significance |
|---|---|---|
| Hepatomegaly | Palpate from right iliac fossa upward; assess span by percussion (normal 6-12 cm in midclavicular line) | Tender: hepatitis, congestion, abscess. Non-tender: cirrhosis, infiltrative disease, malignancy |
| Liver edge character | Assess texture of palpable liver edge | Smooth: normal, hepatitis. Nodular/irregular: cirrhosis, metastases. Firm/hard: malignancy |
| Splenomegaly | Palpate from right iliac fossa toward left costal margin; traube space dullness | Suggests portal hypertension (cirrhosis) or hemolytic anemia |
| Palpable gallbladder (Courvoisier sign) | Palpable, non-tender mass in right upper quadrant below liver edge | Painless jaundice with palpable gallbladder suggests malignant biliary obstruction (not gallstones) |
| Murphy sign | Inspiratory arrest during palpation of right upper quadrant | Positive in acute cholecystitis; may be associated with choledocholithiasis |
| Right upper quadrant tenderness | General tenderness on palpation | Hepatitis, cholangitis, biliary colic, hepatic congestion |
| Ascites | Shifting dullness; fluid thrill (if large volume) | Portal hypertension (cirrhosis), malignancy (peritoneal carcinomatosis), cardiac failure |
Percussion
- Liver span: Normal 6-12 cm in midclavicular line; enlarged in hepatomegaly, reduced in advanced cirrhosis (shrunken liver)
- Shifting dullness: Flank dullness that shifts with position change indicates free fluid (ascites)
- Traube space: Dullness in left lower anterior chest suggests splenomegaly
Auscultation
- Hepatic bruit: Systolic bruit over liver suggests hepatocellular carcinoma, alcoholic hepatitis, or arteriovenous malformation
- Venous hum: Continuous hum at umbilicus (portal hypertension with recanalized umbilical vein — Cruveilhier-Baumgarten syndrome)
- Friction rub: Over liver or spleen suggests perihepatitis, splenic infarct, or tumor invasion
Extremities and Skin
Hands
| Finding | Description | Clinical Significance |
|---|---|---|
| Palmar erythema | Reddening of thenar and hypothenar eminences | Chronic liver disease; also seen in pregnancy, thyrotoxicosis, rheumatoid arthritis |
| Dupuytren contracture | Thickening and contracture of palmar fascia, affecting ring and little fingers | Associated with chronic alcohol use (also diabetes, manual labor) |
| Clubbing | Loss of nail bed angle; increased nail curvature | Cirrhosis, hepatopulmonary syndrome; also pulmonary and cardiac disease |
| Leukonychia (white nails) | White discoloration of nail beds (Terry nails, Muehrcke lines) | Hypoalbuminemia in chronic liver disease |
| Asterixis (flapping tremor) | Involuntary flapping movements when wrists are dorsiflexed | Hepatic encephalopathy; also seen in uremia, hypercapnia |
Lower Extremities
- Peripheral edema: Bilateral pitting edema suggests hypoalbuminemia (liver synthetic failure) or right heart failure
- Muscle wasting: Loss of muscle mass in chronic liver disease (sarcopenia)
- Bruising: Easy bruising or ecchymoses suggest coagulopathy
General Skin Findings
- Excoriations: Scratch marks from pruritus (cholestasis)
- Xanthomas: Yellow lipid deposits (primary biliary cholangitis)
- Bronze skin: Hyperpigmentation (hemochromatosis — “bronze diabetes”)
- Paper-money skin: Multiple thin blood vessels on upper body (chronic liver disease)
- Petechiae and purpura: Thrombocytopenia (hypersplenism) or coagulopathy
Neurological Examination
| Finding | Assessment | Significance |
|---|---|---|
| Level of consciousness | Glasgow Coma Scale; response to commands | Altered consciousness suggests hepatic encephalopathy (grade by West Haven criteria) |
| Asterixis | Ask patient to dorsiflex wrists with arms extended; observe for flapping | Present in hepatic encephalopathy grades 2-3; absence does not exclude encephalopathy |
| Constructional apraxia | Ask patient to draw a clock or connect dots | Early sign of hepatic encephalopathy; useful for monitoring |
| Hyperreflexia | Test deep tendon reflexes | May be present in hepatic encephalopathy |
| Kayser-Fleischer rings | Examine cornea (slit lamp for definitive diagnosis) | Wilson disease — copper deposition in Descemet membrane |
Expected Findings by Etiology
| Condition | General Appearance | Abdominal Findings | Other Key Findings |
|---|---|---|---|
| Choledocholithiasis with cholangitis | Acutely ill, febrile, may be jaundiced | Right upper quadrant tenderness; may have Murphy sign; no hepatomegaly | Fever, tachycardia; may have rigors; confusion if severe (Reynolds pentad) |
| Pancreatic head cancer | Cachectic; progressive deep jaundice | Palpable non-tender gallbladder (Courvoisier sign); possible epigastric mass | Weight loss; may have migratory thrombophlebitis (Trousseau sign) |
| Acute viral hepatitis | May appear unwell; variable jaundice | Tender hepatomegaly; minimal splenomegaly | Often normal examination except for jaundice and hepatomegaly |
| Alcoholic hepatitis | May have stigmata of chronic alcohol use | Tender hepatomegaly; may have ascites | Parotid enlargement; Dupuytren contracture; spider angiomata; fever common |
| Cirrhosis (decompensated) | Muscle wasting; spider angiomata; palmar erythema | Shrunken or nodular liver; splenomegaly; ascites; caput medusae | Gynecomastia; testicular atrophy; asterixis if encephalopathy; peripheral edema |
| Hemolytic anemia | Pallor; mild jaundice (lemon-yellow) | Splenomegaly (often marked); no hepatomegaly unless secondary hemosiderosis | Tachycardia; flow murmur; pigment gallstones may coexist |
| Gilbert syndrome | Mild scleral icterus; otherwise healthy appearance | Normal abdominal examination; no hepatomegaly or tenderness | Completely normal examination; diagnosis of exclusion |
| Primary biliary cholangitis | Middle-aged woman; xanthelasma; scratch marks | Hepatomegaly (early); splenomegaly; may develop ascites late | Xanthomas; hyperpigmentation; clubbing in advanced disease |
Important Teaching Point
Normal examination is common! Many causes of jaundice present with minimal or no physical findings beyond the jaundice itself:
- Gilbert syndrome: Entirely normal examination except mild scleral icterus
- Early viral hepatitis: May only have hepatomegaly and mild tenderness
- Drug-induced liver injury: Often normal examination; jaundice may be the only sign
- Early biliary obstruction: May not yet have developed palpable gallbladder or other signs
A normal physical examination does not exclude serious pathology. Laboratory tests and imaging are essential for all patients with new jaundice.
Courvoisier Law — Clinical Application
Classical teaching: In the presence of painless jaundice, a palpable gallbladder is unlikely to be due to gallstones and suggests malignant obstruction.
Rationale: Chronic gallstone disease causes a fibrotic, non-distensible gallbladder that cannot enlarge. Malignant obstruction of a previously healthy gallbladder allows distension.
Exceptions and limitations:
- Sensitivity is only 25-50% — absence of palpable gallbladder does not exclude malignancy
- Obesity makes palpation unreliable
- Double duct sign on imaging (dilated bile and pancreatic ducts) has similar implications
5. Differential Diagnosis
Systematic approach organized by probability, mechanism, and clinical features
Step-by-Step Approach to Jaundice:
- Step 1: Confirm true jaundice — Distinguish from carotenemia (yellow skin but white sclerae) and pseudo-jaundice
- Step 2: Fractionate bilirubin — Is it predominantly conjugated or unconjugated?
- Step 3: Analyze enzyme pattern — Hepatocellular (elevated AST/ALT) or cholestatic (elevated alkaline phosphatase/gamma-glutamyl transferase)?
- Step 4: If cholestatic, obtain imaging — Are bile ducts dilated (extrahepatic obstruction) or non-dilated (intrahepatic cholestasis)?
- Step 5: Integrate clinical features — Duration, pain, associated symptoms, exposures
Unconjugated (Indirect) Hyperbilirubinemia
Defined as greater than 80% of total bilirubin being unconjugated. Urine is negative for bilirubin. Liver enzymes are typically normal or near-normal.
| Probability | Condition | Key Features | Diagnostic Clues |
|---|---|---|---|
| COMMON | Gilbert syndrome | Mild, fluctuating jaundice; worsens with fasting, stress, illness; otherwise asymptomatic | Bilirubin typically 1-3 mg/dL; normal liver enzymes; normal reticulocyte count; diagnosis of exclusion |
| LESS COMMON | Hemolytic anemia (autoimmune, hereditary, drug-induced) | Pallor, fatigue, splenomegaly; “lemon-yellow” jaundice; dark urine (hemoglobinuria, not bilirubinuria) | Elevated lactate dehydrogenase, low haptoglobin, reticulocytosis; Coombs test; blood smear abnormalities |
| LESS COMMON | Ineffective erythropoiesis (thalassemia, megaloblastic anemia) | Chronic mild jaundice; anemia; may have splenomegaly | Low reticulocyte count relative to anemia; specific findings on blood smear; MCV abnormalities |
| UNCOMMON | Crigler-Najjar syndrome | Type I: severe jaundice from birth, risk of kernicterus; Type II: milder, responds to phenobarbital | Very high unconjugated bilirubin; absent or severely reduced UGT1A1 activity; genetic testing available |
| UNCOMMON | Large hematoma resorption | History of trauma; visible bruising; transient jaundice | Temporal relationship with injury; resolves spontaneously; may see elevated lactate dehydrogenase |
Conjugated Hyperbilirubinemia — Hepatocellular Pattern
Elevated conjugated bilirubin with disproportionately elevated transaminases (AST, ALT). R ratio greater than 5. Urine is positive for bilirubin (dark urine).
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Viral hepatitis (Hepatitis A, B, C, E) | Leading cause of acute hepatocellular jaundice worldwide | Prodrome of malaise, anorexia, nausea; AST/ALT often greater than 1000 U/L; exposure history; positive serology |
| COMMON | Alcoholic hepatitis | Common in heavy drinkers; may occur on background of cirrhosis | Recent heavy alcohol use; AST:ALT ratio greater than 2:1; AST rarely exceeds 300 U/L; elevated gamma-glutamyl transferase; fever common |
| COMMON | Drug-induced liver injury | Accounts for approximately 10% of acute hepatitis cases | Temporal relationship with drug (1-8 weeks); improvement after withdrawal; may have eosinophilia, rash |
| LESS COMMON | Autoimmune hepatitis | More common in women; bimodal age distribution | Elevated immunoglobulins (IgG); positive autoantibodies (ANA, anti-smooth muscle, anti-LKM); other autoimmune conditions |
| LESS COMMON | Ischemic hepatitis (shock liver) | Occurs after hypotensive episodes | History of hypotension, cardiac arrest, sepsis; dramatic AST/ALT elevation (often greater than 1000); rapid improvement with supportive care |
| LESS COMMON | Wilson disease | Peak onset age 5-35 years | Kayser-Fleischer rings; low ceruloplasmin; elevated 24-hour urine copper; neuropsychiatric symptoms; hemolytic anemia |
| UNCOMMON BUT SERIOUS | Acute liver failure | Medical emergency; high mortality without transplant | Encephalopathy within 26 weeks of jaundice onset; INR greater than 1.5; no prior liver disease; acetaminophen most common cause |
| UNCOMMON | Budd-Chiari syndrome | Hepatic vein thrombosis | Triad: hepatomegaly, ascites, abdominal pain; underlying hypercoagulable state; Doppler ultrasound diagnostic |
Conjugated Hyperbilirubinemia — Cholestatic Pattern
Elevated conjugated bilirubin with disproportionately elevated alkaline phosphatase and gamma-glutamyl transferase. R ratio less than 2. Dark urine, pale stools, pruritus common.
Extrahepatic Obstruction (Dilated Bile Ducts on Imaging)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 40%) | Choledocholithiasis (common bile duct stone) | Colicky right upper quadrant pain; history of gallstones; may have fever if complicated by cholangitis | Charcot triad (fever, jaundice, right upper quadrant pain); Reynolds pentad adds confusion and hypotension |
| LESS COMMON (approximately 25%) | Pancreatic head adenocarcinoma | Painless progressive jaundice; weight loss; new-onset diabetes; palpable gallbladder | Courvoisier sign; cachexia; Trousseau sign (migratory thrombophlebitis) |
| LESS COMMON (approximately 15%) | Cholangiocarcinoma | Progressive jaundice and pruritus; weight loss; may arise in primary sclerosing cholangitis | Rapidly progressive jaundice; markedly elevated CA 19-9 |
| LESS COMMON | Periampullary tumors (ampullary, duodenal) | Similar to pancreatic cancer; may have intermittent jaundice (tumor necrosis) | Gastrointestinal bleeding; anemia |
| UNCOMMON | Benign biliary stricture | History of previous biliary surgery, chronic pancreatitis, or trauma | Recurrent cholangitis episodes |
| UNCOMMON | Mirizzi syndrome | Large gallstone in cystic duct compressing common hepatic duct | History of chronic cholecystitis; difficult to distinguish from malignancy on imaging |
| UNCOMMON | Parasitic infection (Ascaris, liver flukes) | Endemic areas (Southeast Asia, Latin America); worm in biliary tree | Travel history; eosinophilia; worms visible on imaging |
Intrahepatic Cholestasis (Non-Dilated Bile Ducts on Imaging)
| Probability | Condition | Key Features | Diagnostic Approach |
|---|---|---|---|
| COMMON | Drug-induced cholestasis | Temporal relationship with medication; pruritus prominent; may outlast drug exposure | Medication review (amoxicillin-clavulanate, anabolic steroids, oral contraceptives); improvement after withdrawal |
| COMMON | Sepsis-associated cholestasis | Critically ill patient; jaundice may be first sign of occult infection | Source identification; elevated inflammatory markers; often multifactorial |
| LESS COMMON | Primary biliary cholangitis | Middle-aged women; pruritus precedes jaundice; fatigue; xanthomas | Antimitochondrial antibodies (greater than 95% sensitive); elevated IgM; liver biopsy shows bile duct destruction |
| LESS COMMON | Primary sclerosing cholangitis | Often associated with inflammatory bowel disease (70%); episodic jaundice | MRCP shows “beaded” bile ducts; pANCA often positive; increased cholangiocarcinoma risk |
| LESS COMMON | Intrahepatic cholestasis of pregnancy | Third trimester; intense pruritus (especially palms and soles); resolves after delivery | Elevated bile acids; fetal monitoring essential (increased stillbirth risk) |
| UNCOMMON | Infiltrative liver disease (sarcoidosis, amyloidosis, lymphoma) | Hepatomegaly; elevated alkaline phosphatase often disproportionate to bilirubin | Imaging may show heterogeneous liver; liver biopsy diagnostic |
| UNCOMMON | Total parenteral nutrition-associated cholestasis | Prolonged parenteral nutrition (greater than 2 weeks); seen in critically ill patients | Temporal relationship; improvement with enteral feeding |
| UNCOMMON | Dubin-Johnson syndrome and Rotor syndrome | Benign hereditary conditions; chronic conjugated hyperbilirubinemia; otherwise asymptomatic | Normal liver enzymes; liver biopsy shows black pigment (Dubin-Johnson); diagnosis of exclusion |
Anatomical Approach to Jaundice
Pre-Hepatic (Bilirubin Overproduction)
Hemolytic anemias (autoimmune, hereditary)
Ineffective erythropoiesis
Massive blood transfusion
Hematoma resorption
Rhabdomyolysis (myoglobin)
Hepatic (Hepatocyte Dysfunction)
Viral hepatitis
Alcoholic and non-alcoholic liver disease
Drug-induced liver injury
Autoimmune hepatitis
Wilson disease, hemochromatosis
Cirrhosis (any etiology)
Post-Hepatic Intrahepatic
Primary biliary cholangitis
Primary sclerosing cholangitis
Drug-induced cholestasis
Sepsis-associated cholestasis
Infiltrative disease
Intrahepatic cholestasis of pregnancy
Post-Hepatic Extrahepatic
Choledocholithiasis
Pancreatic head cancer
Cholangiocarcinoma
Biliary strictures
Periampullary tumors
Parasitic infections
Drug-Induced Jaundice — Comprehensive Reference
| Drug or Drug Class | Pattern of Injury | Mechanism | Time to Resolution After Stopping |
|---|---|---|---|
| Acetaminophen (paracetamol) | Hepatocellular | Direct toxicity via NAPQI metabolite; dose-dependent | Days to weeks if not fatal; N-acetylcysteine is antidote |
| Amoxicillin-clavulanate | Cholestatic or mixed | Idiosyncratic; clavulanate component implicated | Weeks to months (can be prolonged); vanishing bile duct syndrome rare |
| Isoniazid | Hepatocellular | Idiosyncratic; toxic metabolite accumulation; CYP2E1 induction by rifampin increases risk | Weeks; can progress to acute liver failure |
| Statins | Hepatocellular or cholestatic | Idiosyncratic; rare | Usually reversible within weeks of stopping |
| Anabolic steroids | Cholestatic (bland) | Impaired bile secretion without inflammation | Weeks to months after discontinuation |
| Oral contraceptives | Cholestatic | Estrogen effect on bile transporters; genetic susceptibility | Usually resolves within 1-2 months; may recur in pregnancy |
| Phenytoin | Hepatocellular (hypersensitivity) | Immune-mediated; part of DRESS syndrome | Weeks; may have prolonged course with DRESS |
| Amiodarone | Hepatocellular (steatohepatitis) | Direct mitochondrial toxicity; resembles alcoholic hepatitis | Months (long half-life); may progress to cirrhosis |
| Methotrexate | Hepatocellular (chronic fibrosis) | Cumulative dose-related; folate antagonism | May be irreversible; monitoring with liver biopsy or elastography |
| Herbal supplements (green tea extract, kava) | Hepatocellular | Variable; often unknown mechanism; contamination possible | Variable; can cause acute liver failure |
| Trimethoprim-sulfamethoxazole | Cholestatic or mixed | Idiosyncratic; sulfonamide hypersensitivity | Weeks; granulomatous hepatitis possible |
| Azathioprine | Cholestatic or veno-occlusive | Endothelial injury; TPMT polymorphism affects risk | Variable; veno-occlusive disease may be severe |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Painless jaundice + weight loss + palpable gallbladder | Pancreatic head cancer | CT abdomen with pancreatic protocol; CA 19-9 |
| Fever + jaundice + right upper quadrant pain (Charcot triad) | Ascending cholangitis | Urgent ERCP; blood cultures; IV antibiotics |
| Young patient + Kayser-Fleischer rings + hemolysis | Wilson disease | Ceruloplasmin; 24-hour urine copper; slit lamp examination |
| Jaundice + asterixis + coagulopathy | Acute liver failure or decompensated cirrhosis | Acetaminophen level; hepatitis serologies; urgent hepatology consultation |
| Middle-aged woman + pruritus + antimitochondrial antibodies | Primary biliary cholangitis | Liver biopsy if diagnosis uncertain; ursodeoxycholic acid treatment |
| Inflammatory bowel disease + cholestatic jaundice | Primary sclerosing cholangitis | MRCP for bile duct imaging; colonoscopy if not done |
| Fluctuating mild jaundice + normal liver tests + young adult | Gilbert syndrome | Fasting test (optional); exclude hemolysis; reassurance |
| Heavy drinker + AST:ALT greater than 2:1 + fever | Alcoholic hepatitis | Maddrey discriminant function; consider steroids if severe |
| Recent drug started + jaundice + eosinophilia + rash | Drug-induced liver injury (hypersensitivity) | Stop offending drug immediately; supportive care |
| Pallor + splenomegaly + reticulocytosis | Hemolytic anemia | Direct Coombs test; haptoglobin; lactate dehydrogenase; blood smear |
| Third trimester + pruritus (palms/soles) + elevated bile acids | Intrahepatic cholestasis of pregnancy | Fetal monitoring; consider early delivery; ursodeoxycholic acid |
| Post-hypotensive episode + AST/ALT greater than 1000 | Ischemic hepatitis | Treat underlying cause; supportive care; rapid improvement expected |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Jaundice
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Total and direct (conjugated) bilirubin | Confirm hyperbilirubinemia; determine if conjugated or unconjugated predominant | Direct greater than 50% of total suggests conjugated; direct less than 20% suggests unconjugated | Fractionation is the single most important initial test; guides entire workup |
| Alanine aminotransferase (ALT) | Assess hepatocellular injury | Elevated greater than 10x upper limit of normal suggests acute hepatocellular injury | More specific to liver than AST; degree of elevation guides differential |
| Aspartate aminotransferase (AST) | Assess hepatocellular injury; calculate AST:ALT ratio | AST:ALT greater than 2:1 suggests alcoholic liver disease; AST:ALT greater than 1 in cirrhosis | Also elevated in muscle injury, hemolysis; less specific than ALT |
| Alkaline phosphatase (ALP) | Assess cholestatic injury | Elevated greater than 3x upper limit of normal suggests cholestasis or infiltrative disease | Also elevated in bone disease, pregnancy; check gamma-glutamyl transferase to confirm hepatic origin |
| Gamma-glutamyl transferase (GGT) | Confirm hepatic source of elevated alkaline phosphatase; assess alcohol use | Elevated with alkaline phosphatase confirms hepatobiliary source | Very sensitive but not specific; induced by alcohol and many drugs |
| Albumin | Assess hepatic synthetic function | Low albumin (less than 3.5 g/dL) suggests chronic liver disease or severe acute illness | Half-life approximately 20 days; not useful for acute liver injury |
| Prothrombin time / INR | Assess hepatic synthetic function | Prolonged PT/elevated INR suggests synthetic failure; INR greater than 1.5 is concerning | Responds within hours; best marker of acute synthetic function; also affected by vitamin K deficiency |
| Complete blood count | Assess for anemia, thrombocytopenia, infection | Anemia (hemolysis, chronic disease); thrombocytopenia (hypersplenism); leukocytosis (infection) | Blood smear essential if hemolysis suspected |
| Basic metabolic panel | Assess renal function and electrolytes | Elevated creatinine may indicate hepatorenal syndrome; electrolyte abnormalities common | Baseline before contrast imaging or procedures |
Calculate the R Ratio: This helps classify the pattern of liver injury.
Formula: R = (ALT ÷ upper limit of normal for ALT) ÷ (ALP ÷ upper limit of normal for ALP)
- R greater than 5: Hepatocellular pattern → Focus on viral hepatitis, drugs, autoimmune hepatitis, Wilson disease
- R less than 2: Cholestatic pattern → Obtain imaging; focus on obstruction versus intrahepatic cholestasis
- R between 2 and 5: Mixed pattern → Consider drug-induced injury, cholangitis with hepatocyte involvement
First-Line Imaging: Abdominal Ultrasound
Why Ultrasound First?
Abdominal ultrasound is the initial imaging modality of choice for jaundice because it:
- Answers the critical question: Are the bile ducts dilated?
- Is non-invasive, widely available, and inexpensive
- Has no radiation exposure
- Identifies gallstones with high sensitivity (greater than 95%)
- Assesses liver parenchyma, spleen, and ascites
Key findings to look for:
- Dilated intrahepatic or extrahepatic ducts: Confirms extrahepatic obstruction
- Common bile duct diameter: Greater than 6 mm is abnormal (greater than 8-10 mm after cholecystectomy)
- Gallstones: In gallbladder or common bile duct
- Pancreatic mass: May be visible; CT better for pancreatic evaluation
- Liver parenchyma: Cirrhosis, focal lesions, hepatomegaly
Targeted Investigations by Suspected Etiology
If Suspecting Viral Hepatitis
First-Line Tests
- Hepatitis A IgM: Positive in acute hepatitis A infection
- Hepatitis B surface antigen (HBsAg): Positive indicates current infection
- Hepatitis B core IgM antibody (anti-HBc IgM): Positive indicates acute infection
- Hepatitis C antibody (anti-HCV): Screen for hepatitis C exposure
Second-Line Tests
- Hepatitis C RNA (viral load): Confirms active infection if antibody positive
- Hepatitis B DNA and e-antigen: Assess viral replication
- Hepatitis E IgM: Consider in travelers, pregnant women, immunocompromised
- Other viruses: EBV, CMV if atypical presentation or immunocompromised
If Suspecting Autoimmune Liver Disease
First-Line Tests
- Antinuclear antibody (ANA): Positive in approximately 70% of autoimmune hepatitis
- Anti-smooth muscle antibody (ASMA): More specific for autoimmune hepatitis type 1
- Immunoglobulin levels (IgG, IgM): Elevated IgG in autoimmune hepatitis; elevated IgM in primary biliary cholangitis
- Antimitochondrial antibody (AMA): Greater than 95% specific for primary biliary cholangitis
Second-Line Tests
- Anti-liver kidney microsomal antibody (anti-LKM): Autoimmune hepatitis type 2
- pANCA: Often positive in primary sclerosing cholangitis
- Liver biopsy: For definitive diagnosis and staging; interface hepatitis characteristic
- MRCP: For primary sclerosing cholangitis if suspected
If Suspecting Biliary Obstruction (Dilated Ducts on Ultrasound)
First-Line Tests
- CT abdomen with contrast: Better for pancreatic masses, lymphadenopathy, staging
- MRCP (magnetic resonance cholangiopancreatography): Non-invasive visualization of biliary tree; excellent for stones and strictures
- Tumor markers: CA 19-9 (pancreatic and biliary cancer); CEA if metastatic disease suspected
Therapeutic/Diagnostic Procedures
- ERCP (endoscopic retrograde cholangiopancreatography): Both diagnostic and therapeutic; stone extraction, stent placement, brushings for cytology
- Endoscopic ultrasound (EUS): Best for ampullary lesions and small pancreatic masses; allows FNA biopsy
- Percutaneous transhepatic cholangiography: If ERCP fails or not possible; allows drainage
If Suspecting Hemolysis
First-Line Tests
- Reticulocyte count: Elevated (greater than 2%) indicates increased red cell production
- Lactate dehydrogenase (LDH): Elevated in hemolysis (released from red cells)
- Haptoglobin: Low or undetectable (binds free hemoglobin and is cleared)
- Direct Coombs test (direct antiglobulin test): Positive in autoimmune hemolytic anemia
Second-Line Tests
- Peripheral blood smear: Spherocytes, schistocytes, sickle cells, bite cells
- Hemoglobin electrophoresis: Sickle cell disease, thalassemia
- G6PD level: Test when not acutely hemolyzing (false negative during episodes)
- Osmotic fragility: Hereditary spherocytosis
If Suspecting Wilson Disease
First-Line Tests
- Serum ceruloplasmin: Low (less than 20 mg/dL) in most cases; can be normal in acute liver failure
- Slit lamp examination: Kayser-Fleischer rings (copper in Descemet membrane)
- 24-hour urine copper: Elevated (greater than 100 mcg/day); greater than 40 mcg/day suspicious
Second-Line Tests
- Hepatic copper content (liver biopsy): Greater than 250 mcg/g dry weight is diagnostic
- Genetic testing: ATP7B gene mutations
- MRI brain: If neuropsychiatric symptoms; basal ganglia changes
If Suspecting Acute Liver Failure
| Investigation | Purpose | Critical Values |
|---|---|---|
| Acetaminophen level | Most common cause of acute liver failure; N-acetylcysteine is antidote | Any detectable level in context of liver failure is significant |
| INR | Assess synthetic function and prognosis | INR greater than 1.5 with encephalopathy defines acute liver failure |
| Ammonia level | Correlates with encephalopathy; guides management | Elevated; serial levels to monitor |
| Arterial blood gas and lactate | Assess metabolic status; lactate prognostic | Acidosis and elevated lactate indicate poor prognosis |
| Factor V level | Prognostic marker (short half-life) | Factor V less than 20% indicates very poor prognosis |
| Viral hepatitis panel | Identify viral etiology | Hepatitis A, B (including HBV DNA), and E serologies |
| Autoimmune markers | Autoimmune hepatitis can present as acute liver failure | ANA, ASMA, immunoglobulins |
| Ceruloplasmin and urine copper | Wilson disease presenting as acute liver failure | Low ceruloplasmin; very high urine copper; Coombs-negative hemolysis |
Empiric Treatment Trials as Diagnostic Tools
When Empiric Therapy Helps Establish Diagnosis
In some cases, response to treatment supports the diagnosis:
- Drug withdrawal: If drug-induced liver injury suspected, stop the offending agent. Improvement within days to weeks supports the diagnosis. Note: some drugs (amoxicillin-clavulanate) may have delayed resolution.
- Ursodeoxycholic acid trial: Response in primary biliary cholangitis; also used in intrahepatic cholestasis of pregnancy.
- Corticosteroid trial: In autoimmune hepatitis, dramatic response to steroids supports diagnosis. In alcoholic hepatitis with Maddrey score greater than 32, steroids may improve outcomes.
- Phenobarbital test: In Gilbert syndrome, phenobarbital induces UGT1A1 enzyme and reduces bilirubin levels (rarely used clinically).
- Fasting test: In Gilbert syndrome, 48-hour fast increases unconjugated bilirubin by greater than 100% (confirms diagnosis but rarely needed).
Advanced and Specialized Investigations
| Investigation | When to Order | What It Shows |
|---|---|---|
| Liver biopsy | Diagnostic uncertainty; staging of chronic liver disease; suspected infiltrative disease | Histological diagnosis; fibrosis staging; specific patterns (interface hepatitis, granulomas, steatosis) |
| Transient elastography (FibroScan) | Non-invasive assessment of liver fibrosis; monitoring chronic liver disease | Liver stiffness correlates with fibrosis stage; elevated in acute inflammation (false positive) |
| MRCP | Non-invasive bile duct imaging; suspected primary sclerosing cholangitis; evaluate strictures | “Beaded” appearance in primary sclerosing cholangitis; strictures; stones |
| Endoscopic ultrasound (EUS) | Pancreatic mass evaluation; ampullary lesions; FNA biopsy needed | Superior for small pancreatic lesions; allows tissue diagnosis |
| Hepatic venography / liver Doppler | Suspected Budd-Chiari syndrome; portal vein thrombosis | Hepatic vein patency; portal vein flow; collateral circulation |
| Alpha-fetoprotein | Chronic liver disease; hepatocellular carcinoma screening | Elevated in hepatocellular carcinoma (also elevated in acute hepatitis, pregnancy) |
| Ferritin and transferrin saturation | Suspected hemochromatosis; unexplained liver disease | Elevated ferritin and transferrin saturation greater than 45% suggest iron overload |
| Alpha-1 antitrypsin level and phenotype | Unexplained liver disease; young patient with cirrhosis | Low level with PiZZ phenotype diagnostic; PAS-positive globules on biopsy |
Diagnostic Algorithm Summary:
- All patients: Liver panel (bilirubin fractionation, AST, ALT, ALP, GGT, albumin, INR), CBC, BMP
- Calculate R ratio to classify as hepatocellular, cholestatic, or mixed
- Obtain abdominal ultrasound to assess bile duct caliber
- If ducts dilated: CT or MRCP → ERCP if obstruction confirmed
- If ducts not dilated: Pursue etiology based on enzyme pattern (viral serologies, autoimmune markers, drug history)
- If unconjugated predominant: Evaluate for hemolysis versus Gilbert syndrome
- Consider liver biopsy when diagnosis remains uncertain after non-invasive workup
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for jaundice
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Fever + jaundice + right upper quadrant pain (Charcot triad) | EMERGENT | Resuscitation; blood cultures; IV antibiotics; urgent ERCP within 24 hours (or emergent if Reynolds pentad) |
| Jaundice + altered mental status + coagulopathy (INR greater than 1.5) | EMERGENT | Suspect acute liver failure; check acetaminophen level; contact hepatology/transplant center; ICU admission |
| Jaundice + hypotension or signs of sepsis | EMERGENT | Sepsis protocol; identify source (cholangitis, spontaneous bacterial peritonitis, other); aggressive fluid resuscitation |
| Jaundice in pregnancy (especially third trimester) | EMERGENT | Evaluate for HELLP syndrome, acute fatty liver of pregnancy; obstetric and hepatology consultation; fetal monitoring |
| Painless jaundice with weight loss in elderly patient | URGENT | High suspicion for malignancy; expedited CT abdomen and tumor markers; outpatient workup acceptable if stable |
| New jaundice with significantly elevated transaminases (greater than 1000 U/L) | URGENT | Acute hepatitis workup; viral serologies; check synthetic function (INR); monitor for progression to liver failure |
| Jaundice with colicky abdominal pain, otherwise stable | URGENT | Likely choledocholithiasis; ultrasound; may need ERCP or MRCP; admit for observation and analgesia |
| Chronic mild jaundice, normal liver enzymes, otherwise well | ROUTINE | Likely Gilbert syndrome; outpatient workup; confirm with bilirubin fractionation; exclude hemolysis |
| Known cirrhosis with worsening jaundice | URGENT | Assess for precipitant (infection, bleeding, medication, hepatocellular carcinoma); may indicate decompensation |
Step 2: Classify by Bilirubin Type
Predominantly Unconjugated (greater than 80% indirect)
Key question: Is there evidence of hemolysis?
Proceed to Algorithm A
Predominantly Conjugated (greater than 50% direct)
Key question: What is the enzyme pattern (hepatocellular vs cholestatic)?
Proceed to Algorithm B or C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Unconjugated Hyperbilirubinemia
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Mild jaundice (bilirubin 1-3 mg/dL) + normal hemoglobin + normal reticulocytes + normal liver enzymes | Gilbert syndrome | Reassurance; no treatment needed; educate about triggers (fasting, illness); diagnosis of exclusion |
| Anemia + elevated reticulocytes + elevated LDH + low haptoglobin | Hemolytic anemia | Direct Coombs test; blood smear; identify cause (autoimmune, hereditary, drug-induced, microangiopathic) |
| Anemia + LOW reticulocytes + macrocytosis or hypersegmented neutrophils | Ineffective erythropoiesis (megaloblastic anemia, myelodysplasia) | Vitamin B12 and folate levels; bone marrow biopsy if indicated |
| Severe unconjugated hyperbilirubinemia (greater than 20 mg/dL) + no hemolysis + infant or young child | Crigler-Najjar syndrome | Genetic testing; phototherapy; liver transplant evaluation for type I |
| Recent trauma + visible hematoma + transient jaundice | Hematoma resorption | Observation; self-limited; resolves as hematoma absorbs |
Algorithm B: Conjugated Hyperbilirubinemia — Hepatocellular Pattern (R greater than 5)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| AST/ALT greater than 1000 U/L + positive viral serologies + prodrome of malaise | Acute viral hepatitis | Supportive care; monitor for progression; hepatitis A and E are self-limited; hepatitis B may need antiviral |
| Heavy alcohol use + AST:ALT greater than 2:1 + AST less than 300 U/L + fever | Alcoholic hepatitis | Calculate Maddrey discriminant function; steroids if greater than 32; nutrition; alcohol cessation |
| New medication in past 1-8 weeks + elevated transaminases + possible rash/eosinophilia | Drug-induced liver injury | Stop offending drug immediately; supportive care; monitor for improvement; report to pharmacovigilance |
| Positive autoantibodies (ANA, ASMA) + elevated IgG + young to middle-aged woman | Autoimmune hepatitis | Liver biopsy for confirmation and staging; initiate steroids and azathioprine |
| Recent hypotensive episode + AST/ALT greater than 1000 U/L + rapid improvement | Ischemic hepatitis | Treat underlying cause (cardiogenic shock, sepsis); supportive care; expect rapid enzyme improvement |
| Young patient + Kayser-Fleischer rings + low ceruloplasmin + hemolysis | Wilson disease | 24-hour urine copper; liver biopsy; initiate chelation therapy; screen family members |
| Encephalopathy + coagulopathy (INR greater than 1.5) + no prior liver disease | Acute liver failure | ICU admission; acetaminophen level; N-acetylcysteine; urgent transplant evaluation; treat cerebral edema |
Algorithm C: Conjugated Hyperbilirubinemia — Cholestatic Pattern (R less than 2)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Dilated bile ducts on ultrasound + colicky pain + gallstones | Choledocholithiasis | MRCP to confirm; ERCP for stone extraction; cholecystectomy to prevent recurrence |
| Dilated bile ducts + fever + right upper quadrant pain (Charcot triad) | Ascending cholangitis | Blood cultures; IV antibiotics; urgent ERCP for drainage (emergent if Reynolds pentad) |
| Dilated bile ducts + painless progressive jaundice + weight loss + palpable gallbladder | Pancreatic head cancer or cholangiocarcinoma | CT with pancreatic protocol; CA 19-9; EUS with FNA; surgical oncology referral |
| Non-dilated ducts + middle-aged woman + pruritus + positive antimitochondrial antibodies | Primary biliary cholangitis | Start ursodeoxycholic acid; liver biopsy if diagnosis uncertain; monitor for complications |
| Non-dilated ducts + history of inflammatory bowel disease + “beaded” ducts on MRCP | Primary sclerosing cholangitis | MRCP; colonoscopy (if not done); surveillance for cholangiocarcinoma; ursodeoxycholic acid (controversial) |
| Non-dilated ducts + recent medication started + normal or mildly elevated transaminases | Drug-induced cholestasis | Stop offending drug; supportive care; cholestyramine for pruritus; may take weeks to months to resolve |
| Non-dilated ducts + critically ill patient + sepsis | Sepsis-associated cholestasis | Treat underlying infection; supportive care; jaundice typically resolves with sepsis treatment |
| Third trimester pregnancy + intense pruritus + elevated bile acids | Intrahepatic cholestasis of pregnancy | Ursodeoxycholic acid; fetal monitoring; plan for early delivery (37 weeks); resolves postpartum |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Ultrasound shows dilated ducts but no visible cause | Order CT abdomen with contrast or MRCP | If still no cause seen, consider EUS (best for small ampullary and pancreatic lesions) |
| Patient is on multiple medications — which one caused the jaundice? | Review LiverTox database for each medication; prioritize drugs started within 1-8 weeks | Stop most likely culprit first; if must continue a suspect drug, close monitoring |
| Patient has jaundice but all serologies and imaging are negative | Recheck detailed medication and supplement history; consider liver biopsy | Biopsy may reveal unexpected diagnosis (granulomatous disease, infiltration, small duct primary sclerosing cholangitis) |
| Gilbert syndrome is suspected — how do I confirm? | Confirm unconjugated hyperbilirubinemia with normal liver enzymes, CBC, and reticulocyte count | Diagnosis of exclusion; fasting test rarely needed; genetic testing available but usually unnecessary |
| Bilirubin is rising rapidly despite treatment | Reassess diagnosis; check synthetic function (INR); consider obstruction not adequately drained | If acute liver failure developing, urgent hepatology/transplant consultation |
| Patient with cirrhosis develops new jaundice | Look for precipitant: infection (paracentesis if ascites), GI bleeding, medication, hepatocellular carcinoma, portal vein thrombosis | May indicate decompensation; reassess MELD score; consider transplant evaluation if not already listed |
| Jaundice persists weeks after biliary obstruction was relieved | Consider delta bilirubin (covalently bound to albumin; half-life 17-20 days) | Reassurance; no intervention needed; will resolve slowly over weeks |
| Patient refuses liver biopsy | Discuss risks and benefits; consider non-invasive alternatives (elastography, serology patterns) | Empiric treatment may be reasonable in some cases (autoimmune hepatitis with classic features) |
When to Refer to Specialist
Refer to Gastroenterology/Hepatology
- Acute liver failure (urgent/emergent)
- Suspected autoimmune hepatitis
- Primary biliary cholangitis or primary sclerosing cholangitis
- Wilson disease or other metabolic liver disease
- Chronic hepatitis B or C requiring treatment
- Cirrhosis for ongoing management
- Liver biopsy needed
- Diagnostic uncertainty after initial workup
Refer to Surgery/Interventional
- ERCP needed (choledocholithiasis, cholangitis, malignant obstruction)
- Surgical candidate with resectable pancreatic or biliary malignancy
- Cholecystectomy for symptomatic gallstone disease
- Percutaneous drainage if ERCP not possible
- Transplant evaluation for acute liver failure or end-stage liver disease
Troubleshooting Persistent or Unexplained Jaundice
Ask These Questions When Jaundice Doesn’t Resolve or Diagnosis Is Unclear
- Have I excluded all medications, supplements, and herbal products? — Obtain a complete list; check LiverTox database
- Is the obstruction completely relieved? — Repeat imaging; consider stent dysfunction or missed second lesion
- Am I dealing with delta bilirubin? — Conjugated bilirubin bound to albumin persists for weeks after resolution
- Could there be multiple overlapping causes? — Common in hospitalized patients (sepsis + drugs + TPN)
- Is the diagnosis correct? — Consider liver biopsy for tissue diagnosis
- Have I considered rare causes? — Dubin-Johnson syndrome, Rotor syndrome, infiltrative disease, vascular causes
- Is alcohol use ongoing? — Continued drinking prevents recovery in alcoholic liver disease
- Could this be hepatocellular carcinoma? — Check AFP; ensure adequate imaging in cirrhotic patients
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Bilirubin fractionation is the most important initial test: Determining whether hyperbilirubinemia is conjugated or unconjugated immediately narrows the differential and guides the entire workup.
Scleral icterus appears before skin jaundice: The high elastin content of the sclera has strong affinity for bilirubin. Always examine the sclerae in natural light under the upper eyelid for early detection.
Painless jaundice is malignancy until proven otherwise: Progressive jaundice without pain, especially with weight loss, should prompt urgent imaging for pancreatic or biliary malignancy.
Gilbert syndrome is common and benign: Affecting 5-10% of the population, it is the most common cause of isolated unconjugated hyperbilirubinemia. Patients need reassurance, not extensive workup, once hemolysis is excluded.
AST:ALT ratio greater than 2:1 suggests alcoholic liver disease: This pattern occurs because alcohol induces AST (mitochondrial damage) while depleting pyridoxal phosphate (needed for ALT synthesis). Also, AST rarely exceeds 300 U/L in alcoholic hepatitis.
Charcot triad is a surgical emergency: Fever, jaundice, and right upper quadrant pain indicate ascending cholangitis. Do not delay—these patients can deteriorate rapidly to septic shock (Reynolds pentad).
Dark urine precedes jaundice in conjugated hyperbilirubinemia: Water-soluble conjugated bilirubin is excreted in urine, causing dark (“tea-colored”) urine often before skin yellowing is noticed.
Always check INR in jaundiced patients: Prothrombin time/INR is the best real-time marker of hepatic synthetic function. An elevated INR with encephalopathy defines acute liver failure and requires urgent action.
Critical Pitfalls to Avoid
Assuming jaundice in elderly is “just gallstones”: Painless jaundice with weight loss in older patients is pancreatic or biliary malignancy until proven otherwise. Do not delay imaging.
Missing drug-induced liver injury: Always take a thorough medication history including over-the-counter drugs, supplements, and herbal products. Amoxicillin-clavulanate is a common culprit with delayed presentation.
Forgetting to check acetaminophen level in acute liver failure: Acetaminophen toxicity is the most common cause of acute liver failure in developed countries. N-acetylcysteine is life-saving if given early.
Relying on normal ultrasound to exclude obstruction: Early obstruction may not yet cause ductal dilation. If clinical suspicion is high, proceed to CT or MRCP even with normal ultrasound.
Confusing carotenemia with jaundice: Carotenemia (from excess carrot or sweet potato intake) causes yellow skin but spares the sclerae. Always check the sclerae—white sclerae exclude true jaundice.
Delaying ERCP in cholangitis: Ascending cholangitis is a true emergency. Antibiotics alone are not sufficient—source control (ERCP drainage) is essential. Delay increases mortality.
Overlooking sepsis as a cause of jaundice: In critically ill patients, jaundice may be the first sign of occult infection. Sepsis-associated cholestasis is common and often multifactorial.
Missing Wilson disease in young patients: Any patient under 40 with unexplained liver disease should be screened for Wilson disease (ceruloplasmin, slit lamp examination). It is treatable if caught early.
Key Takeaways
- Fractionate bilirubin first: The distinction between conjugated and unconjugated hyperbilirubinemia is the foundation of the entire diagnostic approach.
- Calculate the R ratio: Use the ALT-to-alkaline phosphatase ratio to classify injury as hepatocellular (R greater than 5), cholestatic (R less than 2), or mixed (R 2-5).
- Ultrasound answers the key question: Are the bile ducts dilated? This separates extrahepatic obstruction from intrahepatic causes of cholestasis.
- Recognize emergencies: Charcot triad (cholangitis), Reynolds pentad (severe cholangitis), and acute liver failure (encephalopathy plus coagulopathy) require immediate intervention.
- Take a complete medication history: Drug-induced liver injury is common and often missed. Include supplements, herbals, and over-the-counter products.
- Consider the patient’s age and risk factors: Painless jaundice in elderly patients suggests malignancy; young patients warrant Wilson disease screening.
- Gilbert syndrome is a diagnosis of exclusion: Confirm unconjugated predominance, normal liver enzymes, no hemolysis, and no other explanation before reassuring the patient.
- Synthetic function matters more than bilirubin level: INR and albumin indicate how well the liver is functioning; high bilirubin with preserved synthetic function has a better prognosis.
- Multiple causes may coexist: Especially in hospitalized patients, jaundice may result from several overlapping factors (sepsis, drugs, TPN, hypoperfusion).
- Delta bilirubin explains delayed resolution: Conjugated bilirubin covalently bound to albumin persists for weeks after the underlying cause is corrected.
Quick Reference Algorithm
Systematic Approach to Jaundice:
- Confirm true jaundice: Examine sclerae in natural light; distinguish from carotenemia (sclerae are white in carotenemia)
- Assess stability: Check vital signs, mental status, and INR; identify emergencies (cholangitis, acute liver failure)
- Order baseline labs: Total and direct bilirubin, AST, ALT, alkaline phosphatase, GGT, albumin, INR, CBC
- Fractionate bilirubin: Unconjugated predominant? Think hemolysis or Gilbert syndrome. Conjugated predominant? Calculate R ratio
- Calculate R ratio: Hepatocellular (greater than 5) → viral serologies, autoimmune markers, drug review. Cholestatic (less than 2) → imaging
- Obtain ultrasound: Dilated ducts → CT/MRCP → ERCP. Non-dilated ducts → intrahepatic cholestasis workup
- Pursue specific diagnosis: Based on pattern, serologies, imaging, and clinical features; consider liver biopsy if uncertain
- Treat underlying cause: Stone extraction, stop offending drug, initiate appropriate medical therapy, or refer for surgery/transplant